Purple Biotech Ltd PPBT Q1 2025 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances AAPL Q1 2026 Earnings EPS Beat Drives Modest Stock Gain GAUZ Q2 2025 Earnings Significant EPS Miss Amid Challenging Quarter GTY Q1 2026 Earnings Strong EPS Surprise Drives Investor Interest Despite Modest Stock Decline Immunic Q1 2026 Earnings EPS Miss but Stock Surges 6 as Clinical Progress May Lift Sentiment Crown Castle Q1 2026 Earnings EPS Misses Estimates by 133 Stock Declines